Skip to main content
[Preprint]. 2025 Jul 18:2025.05.22.651305. Originally published 2025 May 27. [Version 2] doi: 10.1101/2025.05.22.651305

Table 3:

Cross-resistance profile to select ADC payloads in cells expressing P-gp, ABCG2 or MRP1

Drug pcDNA MDR19 RR R5 RR MRP1 RR
DM1 (nM) 7.8±1.4 410±120 52 35±4.1 4.5 9.5±3.7 1.2
DM4 (nM) 0.43±0.075 42±20 96 1.4±0.49 3.3 0.58±0.37 1.3
MMAE (nM) 0.90±0.23 360±110 400 5.1±1.9 5.7 1.2±0.80 1.3
MMAF (μM) 0.99±.097 2.0±1.7 2.0 0.99±.097 1.0 1.0±0.39 1.0
Calicheamicin gamma1 0.010±0.0042 0.73±0.41 71 0.029±0.0047 2.9 0.028±0.017 2.7
Exatecan (nM) 0.59±0.19 1.4±0.15 2.4 5.0±0.80 8.5 1.0±0.19 1.8
Deruxtecan (nM) 0.82±0.18 17±1.2 20 190±29 240 1.1±0.40 1.4
Nemorubicin (nM) 0.76±0.31 1.5±0.15 2.0 1.1±0.27 1.4 1.6±0.21 2.2
PNU-159682 (pM) 13±9.6 16±3.7 1.2 13±8.4 1.0 19±8.6 1.4
SJG136 (nM) 0.098±0.019 16±6.2 170 4.6±0.68 47 1.2±1.1 12
SGD-1882 (nM) 0.0066±0.0028 0.85±0.34 130 0.22±0.093 33 0.095±0.036 14
SG2057 (nM) 0.025±0.0087 5.7±1.2 230 0.73±0.34 29 0.27±0.20 11
SG3199 (nM) 0.045±0.011 5.6±1.6 120 0.90±0.31 20 0.21±0.026 4.6

Results are mean GI50 values +/− standard deviation. Relative resistance (RR) value was computed by dividing the GI50 value for the lines expressing the ABC transporters by the empty vector (pcDNA) line. Results are from 3 independent experiments.